Khoury Dirar S, Naware Mihir, Siou Jeff, Blomqvist Andreas, Mathuria Nilesh S, Wang Jianwen, Shih Hue-Teh, Nagueh Sherif F, Panescu Dorin
Department of Cardiology, Methodist DeBakey Heart and Vascular Center, Methodist Hospital Research Institute, 6565 Fannin Street, Houston, TX 77030, USA.
J Am Coll Cardiol. 2009 Mar 24;53(12):1075-81. doi: 10.1016/j.jacc.2008.12.018.
This study was designed to investigate the properties of multiple bioelectric impedance signals recorded during congestive heart failure (CHF) by utilizing various electrode configurations of an implanted cardiac resynchronization therapy system.
The monitoring of CHF has relied mainly on right-side heart sensors.
Fifteen normal dogs underwent implantation of cardiac resynchronization therapy systems using standard leads. An additional left atrial (LA) pressure lead sensor was implanted in 5 dogs. Continuous rapid right ventricular (RV) pacing was applied over several weeks. Left ventricular (LV) catheterization and echocardiography were performed biweekly. Six steady-state impedance signals, utilizing intrathoracic and intracardiac vectors, were measured through ring (r), coil (c), and device Can electrodes.
Congestive heart failure developed in all animals after 2 to 4 weeks of pacing. Impedance diminished gradually during CHF induction, but at varying rates for different vectors. Impedance during CHF decreased significantly in all measured vectors: LV(r)-Can, -17%; LV(r)-RV(r), -15%; LV(r)-RA(r), -11%; RV(r)-Can, -12%; RV(c)-Can, -7%; and RA(r)-Can, -5%. The LV(r)-Can vector reflected both the fastest and largest change in impedance in comparison with vectors employing only right-side heart electrodes, and was highly reflective of changes in LV end-diastolic volume and LA pressure.
Impedance, acquired by different lead electrodes, has variable responses to CHF. Impedance vectors employing an LV lead are highly responsive to physiologic changes during CHF. Measuring multiple impedance signals could be useful for optimizing ambulatory monitoring in heart failure patients.
本研究旨在利用植入式心脏再同步治疗系统的各种电极配置,研究充血性心力衰竭(CHF)期间记录的多个生物电阻抗信号的特性。
CHF的监测主要依赖于右侧心脏传感器。
15只正常犬植入使用标准导联的心脏再同步治疗系统。另外5只犬植入左心房(LA)压力导联传感器。持续快速右心室(RV)起搏数周。每两周进行一次左心室(LV)导管插入术和超声心动图检查。通过环形(r)、线圈(c)和设备外壳电极测量利用胸腔内和心内向量的六个稳态阻抗信号。
起搏2至4周后,所有动物均发生充血性心力衰竭。在CHF诱导过程中,阻抗逐渐降低,但不同向量的降低速率不同。CHF期间,所有测量向量的阻抗均显著降低:LV(r)-外壳,-17%;LV(r)-RV(r),-15%;LV(r)-RA(r),-11%;RV(r)-外壳,-12%;RV(c)-外壳,-7%;RA(r)-外壳,-5%。与仅使用右侧心脏电极的向量相比,LV(r)-外壳向量反映了阻抗最快和最大的变化,并且高度反映了LV舒张末期容积和LA压力的变化。
不同导联电极获取的阻抗对CHF有不同的反应。采用LV导联的阻抗向量对CHF期间的生理变化高度敏感。测量多个阻抗信号可能有助于优化心力衰竭患者的动态监测。